Table 2.
Comorbidities of patients receiving TCZ.
| Survived (n = 116) | Deceased (n = 9) | P value | Improved (n = 109) | Not improved (n = 16) | P value | |
|
| ||||||
| Hypertension | 41 | 6 | 0.79 | 38 | 9 | 0.165 |
| Diabetes | 48 | 7 | 0.42 | 46 | 9 | 0.419 |
| Dyslipidemia | 23 | 3 | 0.392 | 22 | 4 | 0.742 |
| Pulmonary disease | 9 | 1 | 0.54 | 8 | 2 | 0.615 |
| Obesity | 57 | 4 | 0.791 | 54 | 7 | 1.00 |
| Cardiovascular disease | 6 | 4 | 0.002 | 5 | 5 | 0.003 |
| Renal insufficiency | 1 | 2 | 0.013 | 0 | 3 | 0.002 |
| Smoking | 10 | 0 | 1.00 | 9 | 1 | 1.00 |
| Others | 26 | 6 | 0.009 | 23 | 9 | 0.005 |